FDA issued a Warning Letter to Tris Pharma Inc. on 3/26/2018 for a previous inspection.
483 Tris Pharma Jan 2019

483 Tris Pharma Jan 2019

Tamil Arasu FDA, Russell Glapion FDA, Jose Hernandez FDA$119.00 - Available Now

FDA investigators audited the Tris Pharma - Monmouth Junction, NJ, United States facility and issued inspectional observations (via FDA 483) on 23 Jan 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 23 Jan 2019
  • Location: Monmouth Junction, United States
  • FEI: 3004712471
Add To Cart